Market Analysis, Insight Recent innovation & upcoming trends Erythropoietin Stimulating Agents Market
The renal tubules produce endogenous erythropoietin (EPO), a glycoprotein hematopoietic hormone. The erythropoiesis mechanism in the bone marrow is controlled and regulated by it. Red blood cell proliferation can be accelerated with the help of erythropoietin stimulating agents (ESAs). For the treatment of anaemia brought on by chemotherapy, HIV, and chronic kidney failure, erythropoietin stimulating drugs are advised. These stimulating substances can also be used to treat low red blood cell counts during complicated surgical procedures.
Browse Related Report:

Comments
Post a Comment